RNA解析/トランスクリプトミクスの世界市場予測(~2025):製品別、技術別、用途別、エンドユーザー別

MarketsandMarketsが発行した調査報告書(BT 2766)
◆英語タイトル:RNA Analysis/ Transcriptomics Market by Product (Reagents, Instruments, Software), Technology (Microarrays, NGS, Sanger), Application (Clinical Diagnostics, Drug Discovery), End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025
◆商品コード:BT 2766
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年11月13日
◆ページ数:194
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥691,600見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥847,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarkets社はRNA解析/トランスクリプトミクスの世界市場が2020年45億ドルから2025年87億ドルまで、年平均13.9%成長すると予想しています。本調査レポートでは、RNA解析/トランスクリプトミクスの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、製品・サービス別(試薬/消耗品、機器、ソフトウェア、サービス)分析、技術別(ポリメラーゼ連鎖反応、シーケンス、マイクロアレイ、RNA干渉(遺伝子サイレンシング))分析、用途別(創薬、臨床診断、トキシコゲノミクス、比較トランスクリプトミクス)分析、エンドユーザー別(製薬・バイオテクノロジー企業、病院・診断センター、学術・研究機関、医薬品開発業務受託機関)分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・RNA解析/トランスクリプトミクスの世界市場規模:製品・サービス別(試薬/消耗品、機器、ソフトウェア、サービス)
・RNA解析/トランスクリプトミクスの世界市場規模:技術別(ポリメラーゼ連鎖反応、シーケンス、マイクロアレイ、RNA干渉(遺伝子サイレンシング))
・RNA解析/トランスクリプトミクスの世界市場規模:用途別(創薬、臨床診断、トキシコゲノミクス、比較トランスクリプトミクス)
・RNA解析/トランスクリプトミクスの世界市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、病院・診断センター、学術・研究機関、医薬品開発業務受託機関)
・RNA解析/トランスクリプトミクスの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period.”
The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market. The increasing focus on biomarker discovery and toxicogenomics, along with the increasing interest in outsourcing services, is expected to offer significant growth opportunities for the players operating in the global RNA analysis/transcriptomics market. On the other hand, the requirement of high capital investments and data management issues are expected to restrain the growth of this market to a certain extent.

“Based on product, the reagents/consumables segment holds the largest market share during the forecast period.”
Based on product & service, the RNA analysis/Transcriptomics market is segmented into reagents/consumables, instruments, software, and services. The reagents/consumables segment accounted for the larger market share in 2019. The increasing demand for high-quality reagents and the repeated use of media and reagents in transcriptome studies. Additionally, the growing R&D activities in the pharmaceutical industry, growing government investments in the field of life science research, and the increasing research being undertaken with integrated omics studies are contributing to the market for consumables.

“Based on technology, the sequencing technologies segment is expected to register the highest CAGR during the forecast period.”
Based on technology, the RNA analysis/transcriptomics market is segmented into microarrays, PCR, sequencing technologies (Sanger sequencing and NGS technologies), and RNAi (gene silencing). The sequencing technologies segment is expected to witness the highest growth during the forecast period. RNA sequencing allows direct access to sequences of mRNA and is an equitable technology, which makes it more suitable for target identification and drug discovery applications. RNA sequencing also helps to overcome several issues associated with microarrays, such as bias and variation due to hybridization and labeling efficiencies. Technological advancements in this segment are further set to drive market growth.

“The drug discovery segment is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019.”
The drug discovery segment accounted for the largest share of the market in 2019. This is attributed to the use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms. The growing need to study a large number of genes to gain a better understanding of gene-to-drug interactions is further expected to drive the use of transcriptomic technologies in drug discovery applications.

“CROs end user segment is expected to grow at the highest CAGR in the RNA analysis/transcriptomics market during the forecast period.”
Based on end user, the RNA analysis/transcriptomics market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers, and contract research organizations. The contract research organizations (CROs) segment is expected to witness the highest growth during the forecast period. CROs provide affordable outlets for companies and academia to pursue new medicines and offer a cost-effective solution to developing drugs. They also support foundations, research institutions, and universities, in addition to government organizations, such as the NIH and EMA. These factors are driving the growth of this segment.

“North America is expected to account for the largest share of the RNA analysis/transcriptomics market in 2019.”
In 2019, North America accounted for the largest share of the RNA analysis/transcriptomics market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of this market segment can be attributed to the increasing development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–5%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the RNA analysis/transcriptomics market:
The key players operating in the RNA analysis/transcriptomics market include Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Fluidigm Corporation (US), Eurofins Scientific (Germany), Sequentia Biotech SL (Spain), Acobiom (France), GenXPro GmbH (Germany), CD Genomics (US), Promega Corporation (US), Lexogen GmbH (Austria), Cenix BioScience GmbH (Germany), Takara Holdings, Inc. (Japan), bioMérieux SA (France), and LC Sciences LLC (US).

Research Coverage:
The report analyzes the RNA analysis/transcriptomics market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, application, end user, and region. The report also includes a product portfolio matrix of various RNA analysis/transcriptomics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report:
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global RNA analysis/transcriptomics market. The report analyzes this market by product, technology, application, and end user.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global RNA analysis/transcriptomics market.
• Market Development: Comprehensive information on the lucrative emerging markets by product, technology, application, and end user.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global RNA analysis/transcriptomics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global RNA analysis/transcriptomics market.

【レポートの目次】

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION & SCOPE 20
1.2.1 INCLUSIONS AND EXCLUSIONS 20
1.2.2 MARKETS COVERED 21
FIGURE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET 21
1.2.3 YEARS CONSIDERED FOR THE STUDY 21
1.3 CURRENCY 22
1.4 STAKEHOLDERS 22
1.5 LIMITATIONS 22
1.6 SUMMARY OF CHANGES 22
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
FIGURE 2 RESEARCH DESIGN 24
2.1.1 SECONDARY RESEARCH 25
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY RESEARCH 27
FIGURE 3 PRIMARY SOURCES 27
2.1.2.1 Key data from primary sources 28
2.1.2.2 Breakdown of primaries 28
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
2.2 MARKET SIZE ESTIMATION 29
FIGURE 5 SEGMENTAL SHARE ANALYSIS ILLUSTRATION 29
FIGURE 6 TOP-DOWN APPROACH 30
2.3 DATA TRIANGULATION APPROACH 32
FIGURE 7 DATA TRIANGULATION METHODOLOGY 32
2.4 MARKET SHARE ESTIMATION 33
2.5 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
FIGURE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE,
2020 VS. 2025 (USD MILLION) 34
FIGURE 9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2020 VS. 2025 (USD MILLION) 35
FIGURE 10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 36
FIGURE 11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 37
FIGURE 12 GEOGRAPHIC ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET 38
4 PREMIUM INSIGHTS 40
4.1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET OVERVIEW 40
FIGURE 13 INCREASING RESEARCH BEING CONDUCTED USING OMICS TECHNOLOGIES TO DRIVE MARKET GROWTH 40
4.2 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY 41
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RNA ANALYSIS/TRANSCRIPTOMICS MARKET IN 2019 41
4.3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 15 MARKET IN CHINA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 42
4.4 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION (2018–2025) 43
FIGURE 16 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET UNTIL 2025 43
4.5 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 44
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DYNAMICS 45
TABLE 1 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS 45
5.2.1 DRIVERS 46
5.2.1.1 Increasing demand for personalized medicine 46
FIGURE 18 LAUNCH OF PERSONALIZED MEDICINE PRODUCTS, 2008–2016 46
5.2.1.2 Increasing pharmaceutical and biotechnology R&D expenditure and government funding 47
FIGURE 19 R&D INVESTMENTS, BY COUNTRY, 2017 VS. 2018 (USD BILLION) 48
5.2.1.3 Growing applications of RNA sequencing in transcriptomics 48
5.2.2 RESTRAINTS 49
5.2.2.1 High capital investments 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 High growth opportunities in emerging markets 49
5.2.3.2 Increasing application of toxicogenomics 50
5.2.3.3 Increasing focus on biomarker discovery 50
5.2.3.4 Rising focus on outsourcing 51
5.2.4 CHALLENGES 51
5.2.4.1 Data management in transcriptomics research 51
5.2.4.2 Lack of effective bioinformatics tools 52
5.2.4.3 Dearth of skilled professionals 52

6 INDUSTRY INSIGHTS 53
6.1 INTRODUCTION 53
6.2 INDUSTRY TRENDS 53
6.2.1 INTEGRATION OF OMICS DATA IN BIOMEDICAL SCIENCES 53
6.2.2 GROWING FOCUS ON MONITORING POST-TRANSLATIONAL MODIFICATIONS 54
6.2.3 SHIFT FROM PLANT-BASED TO GENOME-BASED DRUG DISCOVERY 54
6.2.4 SPATIALLY RESOLVED TRANSCRIPTOMES 55
6.3 STRATEGIC BENCHMARKING 55
TABLE 2 PRODUCT PORTFOLIO ANALYSIS: RNA ANALYSIS/TRANSCRIPTOMICS MARKET 56
6.4 PORTER’S FIVE FORCES ANALYSIS 56
6.4.1 THREAT OF NEW ENTRANTS 56
6.4.2 THREAT OF SUBSTITUTES 57
6.4.3 BARGAINING POWER OF BUYERS 57
6.4.4 BARGAINING POWER OF SUPPLIERS 57
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.5 RELATED MARKET ANALYSIS 58
6.6 COVID-19 IMPACT ON THE RNA ANALYSIS/TRANSCRIPTOMICS MARKET 58
7 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE 60
7.1 INTRODUCTION 61
TABLE 3 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 61
7.2 REAGENTS/CONSUMABLES 61
7.2.1 REAGENTS/CONSUMABLES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 61
TABLE 4 RNA ANALYSIS/TRANSCRIPTOMICS REAGENTS/CONSUMABLES MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 63
7.3 INSTRUMENTS 63
7.3.1 THE NEED FOR ACCURATE ANALYSIS IS DRIVING THE ADOPTION OF AUTOMATED INSTRUMENTS 63
TABLE 5 RNA ANALYSIS/TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 64
7.4 SOFTWARE 65
7.4.1 NEED FOR DATA MANAGEMENT AND QUALITY ENHANCEMENTS OF RESULTS OBTAINED MAKES SOFTWARE SOLUTIONS AN IMPERATIVE PART OF TRANSCRIPTOMICS 65
TABLE 6 RNA ANALYSIS/TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
7.5 SERVICES 66
7.5.1 INCREASING OUTSOURCING OF SERVICES TO PROPEL MARKET GROWTH 66
TABLE 7 RNA ANALYSIS/TRANSCRIPTOMICS SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 67

8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY 68
8.1 INTRODUCTION 69
TABLE 8 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 69
8.2 POLYMERASE CHAIN REACTION 69
8.2.1 REAL-TIME PCR AIDS IN THE QUANTIFICATION OF LOW-COPY TRANSCRIPTS 69
TABLE 9 RNA ANALYSIS/TRANSCRIPTOMICS PCR MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
8.3 SEQUENCING 71
8.3.1 ADVANCES IN NGS MULTIPLEXING CAPABILITIES TO AID MARKET GROWTH 71
TABLE 10 RNA ANALYSIS/TRANSCRIPTOMICS SEQUENCING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 72
8.4 MICROARRAYS 72
8.4.1 WIDE ADOPTION OF MICROARRAYS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH 72
TABLE 11 RNA ANALYSIS/TRANSCRIPTOMICS MICROARRAYS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 73
8.5 RNA INTERFERENCE (GENE SILENCING) 74
8.5.1 TECHNOLOGICAL ADVANCEMENTS ARE SUPPORTING THE ADOPTION OF THIS TECHNIQUE FOR DIAGNOSTICS AND THERAPEUTICS 74
TABLE 12 RNA ANALYSIS/TRANSCRIPTOMICS RNA INTERFERENCE MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 74
9 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION 75
9.1 INTRODUCTION 76
TABLE 13 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
9.2 DRUG DISCOVERY 76
9.2.1 TARGETED SEQUENCING-BASED APPROACHES ARE GAINING MOMENTUM IN THE FIELD OF DRUG DISCOVERY 76
FIGURE 20 R&D INVESTMENTS IN LIFE SCIENCES, 2016–2018 77
TABLE 14 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY,
BY COUNTRY, 2018–2025 (USD MILLION) 78
9.3 CLINICAL DIAGNOSTICS 78
9.3.1 TRANSCRIPTOMICS IS WIDELY ADOPTED FOR THE LARGE-SCALE GENE EXPRESSION PROFILING OF ONCOLOGICAL DISORDERS 78
TABLE 15 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2018–2025 (USD MILLION) 80
9.4 TOXICOGENOMICS 80
9.4.1 INCREASING FOCUS ON ADR STUDIES IS DRIVING THE ADOPTION OF TRANSCRIPTOMICS FOR SYSTEMIC TOXICOLOGY 80
TABLE 16 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2018–2025 (USD MILLION) 81
9.5 COMPARATIVE TRANSCRIPTOMICS 82
9.5.1 TRANSCRIPTIONAL PROFILES ARE BEING WIDELY ADOPTED TO STUDY
THE EVOLUTION AMONG SPECIES 82
TABLE 17 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR COMPARATIVE TRANSCRIPTOMICS, BY COUNTRY, 2018–2025 (USD MILLION) 83
10 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER 84
10.1 INTRODUCTION 85
TABLE 18 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 85
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 85
10.2.1 INCREASING INVESTMENTS FOR ONCOLOGY THERAPEUTICS DRIVING THE USE OF OMICS TECHNOLOGIES 85
TABLE 19 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 86
10.3 HOSPITALS & DIAGNOSTIC CENTERS 87
10.3.1 USE OF WHOLE-BLOOD TRANSCRIPTOME PROFILES FOR DISEASE DIAGNOSTICS IS AIDING MARKET GROWTH 87
TABLE 20 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2018–2025 (USD MILLION) 88
10.4 ACADEMIC & RESEARCH INSTITUTES 88
10.4.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL MARKET GROWTH 88
TABLE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 89
10.5 CONTRACT RESEARCH ORGANIZATIONS 90
10.5.1 GROWING OUTSOURCING SERVICES BY PHARMACEUTICAL COMPANIES FOR FASTER DRUG DISCOVERY IS AIDING MARKET GROWTH 90
TABLE 22 RNA ANALYSIS/TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 91
11 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION 92
11.1 INTRODUCTION 93
FIGURE 21 RNA ANALYSIS/TRANSCRIPTOMICS MARKET: GEOGRAPHIC SNAPSHOT (2019) 93
TABLE 23 RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY REGION,
2018–2025 (USD MILLION) 94
11.2 NORTH AMERICA 94
FIGURE 22 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 95
TABLE 24 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 25 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 96
TABLE 26 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 96
TABLE 27 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 97
TABLE 28 NORTH AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY END USER, 2018–2025 (USD MILLION) 97
11.2.1 US 97
11.2.1.1 The US dominates the North American market 97
TABLE 29 US: NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020
(USD BILLION) 98
TABLE 30 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 98
TABLE 31 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 99
TABLE 32 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 99
TABLE 33 US: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 100
11.2.2 CANADA 100
11.2.2.1 Improving funding and infrastructure for omics-based research is supporting market growth 100
TABLE 34 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 101
TABLE 35 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 101
TABLE 36 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 102
TABLE 37 CANADA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 102
11.3 EUROPE 102
FIGURE 23 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 104
TABLE 38 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 105
TABLE 39 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 105
TABLE 40 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 106
TABLE 41 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 106
TABLE 42 EUROPE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 106
11.3.1 GERMANY 107
11.3.1.1 Germany holds the largest share of the European market 107
TABLE 43 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 108
TABLE 44 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 108
TABLE 45 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 108
TABLE 46 GERMANY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 109
11.3.2 FRANCE 109
11.3.2.1 Increasing government support for omics-based research in the country to support market growth 109
TABLE 47 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 110
TABLE 48 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 110
TABLE 49 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 111
TABLE 50 FRANCE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 111
11.3.3 UK 111
11.3.3.1 Rising public and private funding for research to drive market growth 111
TABLE 51 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 112
TABLE 52 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 113
TABLE 53 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 113
TABLE 54 UK: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 113
11.3.4 ITALY 114
11.3.4.1 Growth in this market is driven by the improving R&D expenditure and disease diagnostics 114
TABLE 55 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 114
TABLE 56 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 115
TABLE 57 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 115
TABLE 58 ITALY: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 115
11.3.5 SWITZERLAND 116
11.3.5.1 Well-established pharmaceutical industry to drive market growth 116
TABLE 59 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 116
TABLE 60 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 117
TABLE 61 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 117
TABLE 62 SWITZERLAND: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 117
11.3.6 SPAIN 118
11.3.6.1 Increasing collaborations for enhancing research to support market growth 118
TABLE 63 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 118
TABLE 64 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 119
TABLE 65 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 119
TABLE 66 SPAIN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 119
11.3.7 REST OF EUROPE 120
TABLE 67 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 120
TABLE 68 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY,
2018–2025 (USD MILLION) 121
TABLE 69 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 121
TABLE 70 ROE: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 121
11.4 ASIA PACIFIC 122
FIGURE 24 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET SNAPSHOT 123
TABLE 71 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 124
TABLE 72 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 124
TABLE 73 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 124
TABLE 74 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 125
TABLE 75 ASIA PACIFIC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 125
11.4.1 JAPAN 125
11.4.1.1 Early adoption of technologically advanced products to drive
market growth 125
TABLE 76 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 126
TABLE 77 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 127
TABLE 78 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 127
TABLE 79 JAPAN: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 127
11.4.2 CHINA 128
11.4.2.1 China is one of the fastest-growing markets offering significant growth opportunities 128
TABLE 80 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 129
TABLE 81 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 129
TABLE 82 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 129
TABLE 83 CHINA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 130
11.4.3 INDIA 130
11.4.3.1 Increasing pharmaceutical R&D spending and government funding for research to drive market growth 130
TABLE 84 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 131
TABLE 85 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 131
TABLE 86 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 132
TABLE 87 INDIA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 132
11.4.4 REST OF ASIA PACIFIC 132
TABLE 88 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 133
TABLE 89 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 134
TABLE 90 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 134
TABLE 91 ROAPAC: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER,
2018–2025 (USD MILLION) 134
11.5 LATIN AMERICA 135
11.5.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY IN MEXICO TO SUPPORT MARKET GROWTH 135
TABLE 92 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 136
TABLE 93 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 136
TABLE 94 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 136
TABLE 95 LATIN AMERICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET, BY END USER, 2018–2025 (USD MILLION) 137
11.6 MIDDLE EAST & AFRICA 137
11.6.1 IMPROVING FOCUS ON PRECISION MEDICINE AND DISEASE GENETICS IS DRIVING MARKET GROWTH 137
TABLE 96 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY PRODUCT & SERVICE, 2018–2025 (USD MILLION) 138
TABLE 97 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY TECHNOLOGY, 2018–2025 (USD MILLION) 138
TABLE 98 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 139
TABLE 99 MIDDLE EAST & AFRICA: RNA ANALYSIS/TRANSCRIPTOMICS MARKET,
BY END USER, 2018–2025 (USD MILLION) 139
12 COMPETITIVE LANDSCAPE 140
12.1 OVERVIEW 140
FIGURE 25 PRODUCT LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM JANUARY 2017 TO OCTOBER 2020 141
12.2 MARKET SHARE ANALYSIS 142
FIGURE 26 NGS MARKET SHARE, BY KEY PLAYER, 2019 142
FIGURE 27 PCR MARKET SHARE, BY KEY PLAYER, 2019 143
12.3 COMPANY EVALUATION MATRIX 143
12.3.1 STARS 143
12.3.2 EMERGING LEADERS 144
12.3.3 PERVASIVE 144
12.3.4 EMERGING COMPANIES 144
FIGURE 28 RNA ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 145
12.4 COMPETITIVE SITUATION AND TRENDS 146
12.4.1 PRODUCT LAUNCHES 146
TABLE 100 PRODUCT LAUNCHES, 2017–2020 146
12.4.2 EXPANSIONS 146
TABLE 101 EXPANSIONS, 2017–2020 146
12.4.3 ACQUISITIONS 147
TABLE 102 ACQUISITIONS, 2017–2020 147
12.4.4 OTHER STRATEGIES 148
TABLE 103 OTHER STRATEGIES, 2017–2020 148
13 COMPANY PROFILES 149
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 THERMO FISHER SCIENTIFIC, INC. 149
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 149
13.2 AGILENT TECHNOLOGIES, INC. 153
FIGURE 30 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 153
13.3 BIO-RAD LABORATORIES, INC. 157
FIGURE 31 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2019) 157
13.4 CD GENOMICS 159
13.5 PROMEGA CORPORATION 160
13.6 ILLUMINA, INC. 161
FIGURE 32 ILLUMINA, INC.: COMPANY SNAPSHOT (2019) 161
13.7 QIAGEN N.V. 164
FIGURE 33 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 164
13.8 DANAHER CORPORATION 166
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 166
13.9 F. HOFFMANN-LA ROCHE LTD. 169
FIGURE 35 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019) 169
13.10 MERCK KGAA 171
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019) 171
13.11 FLUIDIGM CORPORATION 174
FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019) 174
13.12 EUROFINS SCIENTIFIC 176
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 176
13.13 SEQUENTIA BIOTECH SL 178
13.14 ACOBIOM 179
13.15 GENXPRO GMBH 180
13.16 OTHER COMPANIES 181
13.16.1 LEXOGEN GMBH 181
13.16.2 CENIX BIOSCIENCE GMBH 183
13.16.3 TAKARA HOLDINGS, INC. 184
13.16.4 BIOMÉRIEUX SA 185
13.16.5 LC SCIENCES, LLC 186
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 187
14.1 INSIGHTS OF INDUSTRY EXPERTS 187
14.2 DISCUSSION GUIDE 188
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 193
14.4 AVAILABLE CUSTOMIZATIONS 195
14.5 RELATED REPORTS 195
14.6 AUTHOR DETAILS 196



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ RNA解析/トランスクリプトミクスの世界市場予測(~2025):製品別、技術別、用途別、エンドユーザー別(RNA Analysis/ Transcriptomics Market by Product (Reagents, Instruments, Software), Technology (Microarrays, NGS, Sanger), Application (Clinical Diagnostics, Drug Discovery), End User (CROs, Hospitals), COVID-19 Impact - Global Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆